StonvexLoading…
StonvexStonvexStonvexCore line items from UPST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 |
|---|---|---|---|---|
Revenue | $907.27M | $801.27M | $228.60M | $159.85M |
Operating Income | $-113.86M | $140.88M | $11.77M | $-4.58M |
Net Income | $-108.67M | $135.44M | $5.98M | $-466.00K |
EPS (Diluted) | $-1.31 | $1.43 | $0.00 | $-0.03 |
Total Assets | $1.94B | $1.82B | $477.25M | Not available |
Total Liabilities | $1.26B | $1.01B | $177.00M | Not available |
Cash & Equivalents | $532.47M | $1.19B | $311.33M | $80.07M |
Free Cash Flow OCF − CapEx | $-666.68M | $159.93M | $14.34M | $27.58M |
Shares Outstanding | 81.26M | 83.66M | 73.31M | 14.34M |